{"id":"https://openalex.org/W3200898477","doi":"https://doi.org/10.1200/jco.21.01435","title":"Inhibition of WEE1 Is Effective in TP53 - and RAS -Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring","display_name":"Inhibition of WEE1 Is Effective in TP53 - and RAS -Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring","alternate_titles":[],"publication_year":2021,"publication_date":"2021-09-18","ids":{"openalex":"https://openalex.org/W3200898477","doi":"https://doi.org/10.1200/jco.21.01435","mag":"3200898477","pmid":"https://pubmed.ncbi.nlm.nih.gov/34538072","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8601321"},"language":"en","primary_location":{"id":"doi:10.1200/jco.21.01435","doi":"https://doi.org/10.1200/jco.21.01435","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.21.01435","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.01435","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3200898477"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.01435","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048216705","display_name":"Jenny F. Seligmann","orcid":"https://orcid.org/0000-0003-4379-6005","observed_orcids":["https://orcid.org/0000-0003-4379-6005"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jenny F. Seligmann","raw_affiliation_strings":["Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-4379-6005","affiliations":[{"raw_affiliation_string":"Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073739923","display_name":"David J. Fisher","orcid":"https://orcid.org/0000-0002-2512-2296","observed_orcids":["https://orcid.org/0000-0002-2512-2296"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David J. Fisher","raw_affiliation_strings":["MRC Clinical Trials Unit at UCL, London, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-2512-2296","affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit at UCL, London, United Kingdom","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082693401","display_name":"Louise Clare Brown","orcid":"https://orcid.org/0000-0003-2827-6634","observed_orcids":["https://orcid.org/0000-0003-2827-6634"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Louise C. Brown","raw_affiliation_strings":["MRC Clinical Trials Unit at UCL, London, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-2827-6634","affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit at UCL, London, United Kingdom","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard A. Adams","orcid":"https://orcid.org/0000-0003-3915-7243","observed_orcids":["https://orcid.org/0000-0003-3915-7243"]},"institutions":[{"id":"https://openalex.org/I2799279586","display_name":"Velindre NHS Trust","ror":"https://ror.org/05ntqkc30","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799279586"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard A. Adams","raw_affiliation_strings":["Centre for Trials Research University and Velindre NHS Trust, Cardiff, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-3915-7243","affiliations":[{"raw_affiliation_string":"Centre for Trials Research University and Velindre NHS Trust, Cardiff, United Kingdom","institution_ids":["https://openalex.org/I2799279586"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Janet Graham","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Janet Graham","raw_affiliation_strings":["Beatson Hospital, Glasgow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beatson Hospital, Glasgow, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056121788","display_name":"Philip Quirke","orcid":"https://orcid.org/0000-0002-3597-5444","observed_orcids":["https://orcid.org/0000-0002-3597-5444"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Philip Quirke","raw_affiliation_strings":["Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-3597-5444","affiliations":[{"raw_affiliation_string":"Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023175702","display_name":"Susan D. Richman","orcid":"https://orcid.org/0000-0003-3993-5041","observed_orcids":["https://orcid.org/0000-0003-3993-5041"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Susan D. Richman","raw_affiliation_strings":["Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-3993-5041","affiliations":[{"raw_affiliation_string":"Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rachel Butler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rachel Butler","raw_affiliation_strings":["Bristol Genetics Laboratory, Bristol, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Genetics Laboratory, Bristol, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085287318","display_name":"Enric Domingo","orcid":"https://orcid.org/0000-0003-4390-8767","observed_orcids":["https://orcid.org/0000-0003-4390-8767"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210106471","display_name":"CRUK/MRC Oxford Institute for Radiation Oncology","ror":"https://ror.org/011hz4254","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210106471","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Enric Domingo","raw_affiliation_strings":["MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-4390-8767","affiliations":[{"raw_affiliation_string":"MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210106471"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andrew Blake","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210106471","display_name":"CRUK/MRC Oxford Institute for Radiation Oncology","ror":"https://ror.org/011hz4254","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210106471","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrew Blake","raw_affiliation_strings":["MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210106471"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010957234","display_name":"Emma Yates","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Emma Yates","raw_affiliation_strings":["MRC Clinical Trials Unit at UCL, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit at UCL, London, United Kingdom","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael Braun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Braun","raw_affiliation_strings":["Christie Hospital, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christie Hospital, Manchester, United Kingdom","institution_ids":["https://openalex.org/I4210131968"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Fiona Collinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fiona Collinson","raw_affiliation_strings":["Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rob Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rob Jones","raw_affiliation_strings":["School of Medicine, Cardiff University, Cardiff, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, Cardiff University, Cardiff, United Kingdom","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ewan Brown","orcid":"https://orcid.org/0000-0001-6636-2010","observed_orcids":["https://orcid.org/0000-0001-6636-2010"]},"institutions":[{"id":"https://openalex.org/I2800150677","display_name":"Western General Hospital","ror":"https://ror.org/009kr6r15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1324252669","https://openalex.org/I2800150677"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ewan Brown","raw_affiliation_strings":["Western General Hospital, Edinburgh, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0001-6636-2010","affiliations":[{"raw_affiliation_string":"Western General Hospital, Edinburgh, United Kingdom","institution_ids":["https://openalex.org/I2800150677"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Emma de Winton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800549715","display_name":"Royal United Hospital","ror":"https://ror.org/00a858n67","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800549715","https://openalex.org/I4210161895"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Emma de Winton","raw_affiliation_strings":["Royal United Hospital, Bath, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal United Hospital, Bath, United Kingdom","institution_ids":["https://openalex.org/I2800549715"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Timothy C. Humphrey","orcid":"https://orcid.org/0000-0002-2254-9198","observed_orcids":["https://orcid.org/0000-0002-2254-9198"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210106471","display_name":"CRUK/MRC Oxford Institute for Radiation Oncology","ror":"https://ror.org/011hz4254","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210106471","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Timothy C. Humphrey","raw_affiliation_strings":["MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-2254-9198","affiliations":[{"raw_affiliation_string":"MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210106471"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014097745","display_name":"Mahesh Parmar","orcid":"https://orcid.org/0000-0003-0166-1700","observed_orcids":["https://orcid.org/0000-0003-0166-1700","https://orcid.org/0000-0002-8883-424X"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mahesh Parmar","raw_affiliation_strings":["MRC Clinical Trials Unit at UCL, London, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-0166-1700","affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit at UCL, London, United Kingdom","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053919588","display_name":"Richard S. Kaplan","orcid":"https://orcid.org/0000-0002-0189-8348","observed_orcids":["https://orcid.org/0000-0002-0189-8348"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard Kaplan","raw_affiliation_strings":["MRC Clinical Trials Unit at UCL, London, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-0189-8348","affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit at UCL, London, United Kingdom","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard H. Wilson","orcid":"https://orcid.org/0000-0001-8018-7730","observed_orcids":["https://orcid.org/0000-0001-8018-7730"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard H. Wilson","raw_affiliation_strings":["Beatson Hospital, Glasgow, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0001-8018-7730","affiliations":[{"raw_affiliation_string":"Beatson Hospital, Glasgow, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058562981","display_name":"Michel Seymour","orcid":"https://orcid.org/0000-0002-2441-9629","observed_orcids":["https://orcid.org/0000-0002-2441-9629"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Matthew Seymour","raw_affiliation_strings":["Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-2441-9629","affiliations":[{"raw_affiliation_string":"Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088658336","display_name":"Tim Maughan","orcid":"https://orcid.org/0000-0002-0580-5065","observed_orcids":["https://orcid.org/0000-0002-0580-5065"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210106471","display_name":"CRUK/MRC Oxford Institute for Radiation Oncology","ror":"https://ror.org/011hz4254","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210106471","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Timothy S. Maughan","raw_affiliation_strings":["MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-0580-5065","affiliations":[{"raw_affiliation_string":"MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210106471"]}]},{"author_position":"last","author":{"id":null,"display_name":"on behalf of the FOCUS4 Trial Investigators","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"on behalf of the FOCUS4 Trial Investigators","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5082693401","https://openalex.org/A5088658336"],"corresponding_institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210091428","https://openalex.org/I4210106471","https://openalex.org/I45129253"],"apc_list":null,"apc_paid":null,"fwci":7.3555,"has_fulltext":true,"cited_by_count":128,"citation_normalized_percentile":{"value":0.98610177,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"39","issue":"33","first_page":"3705","last_page":"3715"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11369","display_name":"Genetic factors in colorectal cancer","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9470000267028809},{"id":"https://openalex.org/keywords/adavosertib","display_name":"adavosertib","score":0.8650000095367432},{"id":"https://openalex.org/keywords/azd1775","display_name":"AZD1775","score":0.9440000057220459},{"id":"https://openalex.org/keywords/wee1-kinase-inhibition","display_name":"WEE1 kinase inhibition","score":0.8920000195503235},{"id":"https://openalex.org/keywords/ras-mutations","display_name":"RAS mutations","score":0.8659999966621399},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":1.0},{"id":"https://openalex.org/keywords/active-monitoring","display_name":"active monitoring","score":0.7910000085830688},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9480000138282776},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8640000224113464},{"id":"https://openalex.org/keywords/left-sided-tumors","display_name":"left-sided tumors","score":0.7009999752044678},{"id":"https://openalex.org/keywords/dna-replication","display_name":"DNA replication","score":0.6269999742507935},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.4819999933242798},{"id":"https://openalex.org/keywords/biomarker-guided-therapy","display_name":"biomarker-guided therapy","score":0.3230000138282776},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.4970000088214874}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9359999895095825},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6980999708175659},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6940000057220459},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6577000021934509},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.522599995136261},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.44029998779296875},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.3944999873638153},{"id":"https://openalex.org/C2781252693","wikidata":"https://www.wikidata.org/wiki/Q7979264","display_name":"Wee1","level":5,"score":0.3255000114440918},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.29429998993873596},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2669000029563904},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2538999915122986},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.2522999942302704}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D018631","descriptor_name":"ras Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D057832","descriptor_name":"Watchful Waiting","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true}],"locations_count":8,"locations":[{"id":"doi:10.1200/jco.21.01435","doi":"https://doi.org/10.1200/jco.21.01435","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.21.01435","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.01435","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8601321","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8601321/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Oncol","raw_type":"Text"},{"id":"pmid:34538072","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34538072","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pure.atira.dk:openaire/10d4013e-c81b-4709-b6ad-a33c86056924","doi":null,"is_oa":true,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/10d4013e-c81b-4709-b6ad-a33c86056924","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:eprints.whiterose.ac.uk:178475","doi":null,"is_oa":false,"landing_page_url":"https://eprints.whiterose.ac.uk/178475/6/jco.21.01435.pdf","pdf_url":"https://eprints.whiterose.ac.uk/178475/6/jco.21.01435.pdf","source":{"id":"https://openalex.org/S4306400854","display_name":"White Rose Research Online (University of Leeds, The University of Sheffield, University of York)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800616092","host_organization_name":"White Rose University Consortium","host_organization_lineage":["https://openalex.org/I2800616092"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:https://orca.cardiff.ac.uk:144616","doi":null,"is_oa":false,"landing_page_url":"https://orca.cardiff.ac.uk/id/eprint/144616/1/jco.21.01435%20%281%29.pdf","pdf_url":"https://orca.cardiff.ac.uk/id/eprint/144616/1/jco.21.01435%20%281%29.pdf","source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:10135835","doi":null,"is_oa":false,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/10135835/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Clinical Oncology (2021) (In press).","raw_type":"Article"},{"id":"pmh:oai:figshare.com:article/25381387","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Inhibition_of_WEE1_is_effective_in_TP53-_and_RAS-mutant_metastatic_colorectal_cancer_a_randomized_trial_FOCUS4-C_comparing_adavosertib_AZD1775_with_active_monitoring/25381387","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1200/jco.21.01435","doi":"https://doi.org/10.1200/jco.21.01435","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.21.01435","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.01435","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G3982095159","display_name":null,"funder_award_id":"MC_UU_12023","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G4194262978","display_name":"NIHR Senior Investigator Award","funder_award_id":"NIHR200162","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G6923868637","display_name":"Molecular selection of therapy in metastatic colorectal cancer: a molecularly stratified randomised controlled trial programme (FOCUS 4)","funder_award_id":"11/100/50","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G7076756407","display_name":null,"funder_award_id":"MC_UU_12023/20","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G7201224627","display_name":null,"funder_award_id":"25350","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G8309821602","display_name":"MICA: Stratification in COloRectal cancer: from biology to Treatment prediction: S-CORT","funder_award_id":"MR/M016587/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G8983874826","display_name":"Evaluating new healthcare technologies in cancer","funder_award_id":"MC_UU_00004/01","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320308982","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421"},{"id":"https://openalex.org/F4320314731","display_name":"UK Research and Innovation","ror":"https://ror.org/001aqnf71"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3200898477.pdf","grobid_xml":"https://content.openalex.org/works/W3200898477.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1840165714","https://openalex.org/W2017289276","https://openalex.org/W2019607817","https://openalex.org/W2035263093","https://openalex.org/W2077544467","https://openalex.org/W2096817075","https://openalex.org/W2105590267","https://openalex.org/W2111222453","https://openalex.org/W2129695021","https://openalex.org/W2298480233","https://openalex.org/W2605964154","https://openalex.org/W2897430921","https://openalex.org/W2912626193","https://openalex.org/W2947826965","https://openalex.org/W2954559040","https://openalex.org/W2968502728","https://openalex.org/W3122624214","https://openalex.org/W3163538271"],"related_works":["https://openalex.org/W4207018835","https://openalex.org/W4281674726","https://openalex.org/W4403965859","https://openalex.org/W3202594007","https://openalex.org/W2892347132","https://openalex.org/W2486289563","https://openalex.org/W2528666117","https://openalex.org/W2319308977","https://openalex.org/W4379282188","https://openalex.org/W4237179649"],"abstract_inverted_index":{"PURPOSE":[0],"Outcomes":[1],"in":[2,29,33,227,293],"RAS-mutant":[3],"metastatic":[4],"colorectal":[5],"cancer":[6],"(mCRC)":[7],"remain":[8],"poor":[9],"and":[10,38,57,61,84,101,123,139,263,279],"patients":[11,146,154],"have":[12],"limited":[13],"therapeutic":[14],"options.":[15],"Adavosertib":[16,88,168,252],"is":[17,291],"the":[18],"first":[19],"small-molecule":[20],"inhibitor":[21],"of":[22,76,104,121,297],"WEE1":[23,45],"kinase.":[24],"We":[25],"hypothesized":[26],"that":[27],"aberrations":[28],"DNA":[30],"replication":[31],"seen":[32],"mCRC":[34,52],"with":[35,49,65,115,126,171,199,277],"both":[36,66],"RAS":[37,62],"TP53":[39,60],"mutations":[40,67],"would":[41],"sensitize":[42],"tumors":[43,229],"to":[44,188,214,236,246],"inhibition.":[46],"METHODS":[47],"Patients":[48],"newly":[50],"diagnosed":[51],"were":[53,69,78,147,151,155,258],"registered":[54],"into":[55],"FOCUS4":[56],"tested":[58],"for":[59,286],"mutations.":[63],"Those":[64],"who":[68],"stable":[70],"or":[71,91],"responding":[72],"after":[73],"16":[74],"weeks":[75],"chemotherapy":[77],"randomly":[79,156],"assigned":[80,157],"2:1":[81],"between":[82,136],"adavosertib":[83,200,223,273],"active":[85],"monitoring":[86],"(AM).":[87],"(250":[89],"mg":[90],"300":[92],"mg)":[93],"was":[94,111,134,169,196,225,253],"taken":[95],"orally":[96],"once":[97],"on":[98],"days":[99,102],"1-5":[100],"8-12":[103],"a":[105,116,127,172,283],"3-week":[106],"cycle.":[107],"The":[108],"primary":[109],"outcome":[110],"progression-free":[112],"survival":[113,194],"(PFS),":[114],"target":[117],"hazard":[118],"ratio":[119],"(HR)":[120],"0.5":[122],"80%":[124],"power":[125],"one-sided":[128],"0.025":[129],"significance":[130],"level.":[131],"RESULTS":[132],"FOCUS4-C":[133],"conducted":[135],"April":[137],"2017":[138],"Mar":[140],"2020":[141],"during":[142],"which":[143],"time":[144],"718":[145],"registered;":[148],"247":[149],"(34%)":[150],"RAS/TP53-mutant.":[152],"Sixty-nine":[153],"from":[158],"25":[159],"UK":[160],"hospitals":[161],"(adavosertib":[162],"=":[163,166,183,191,209,217,231,241,250],"44;":[164],"AM":[165,176,202,278],"25).":[167],"associated":[170],"PFS":[173,275],"improvement":[174],"over":[175],"(median":[177,203],"3.61":[178],"v":[179,205],"1.87":[180],"months;":[181,207],"HR":[182,208],"0.35;":[184],"95%":[185,211,233,243],"CI,":[186,212,234,244],"0.18":[187],"0.68;":[189],"P":[190,216,249],".0022).":[192],"Overall":[193],"(OS)":[195],"not":[197],"improved":[198,274],"versus":[201,238],"14.0":[204],"12.8":[206],"0.92;":[210],"0.44":[213],"1.94;":[215],".93).":[218],"In":[219,267],"prespecified":[220],"subgroup":[221],"analysis,":[222],"activity":[224],"greater":[226],"left-sided":[228],"(HR":[230,240],"0.24;":[232],"0.11":[235],"0.51),":[237],"right-sided":[239],"1.02;":[242],"0.41":[245],"2.56;":[247],"interaction":[248],".043).":[251],"well-tolerated;":[254],"grade":[255],"3":[256],"toxicities":[257],"diarrhea":[259],"(9%),":[260],"nausea":[261],"(5%),":[262],"neutropenia":[264],"(7%).":[265],"CONCLUSION":[266],"this":[268,294],"phase":[269],"II":[270],"randomized":[271],"trial,":[272],"compared":[276],"demonstrates":[280],"potential":[281],"as":[282],"well-tolerated":[284],"therapy":[285],"RAS/TP53-mutant":[287],"mCRC.":[288],"Further":[289],"testing":[290],"required":[292],"sizable":[295],"population":[296],"unmet":[298],"need.":[299]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3200898477","counts_by_year":[{"year":2026,"cited_by_count":28},{"year":2025,"cited_by_count":21},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":33},{"year":2022,"cited_by_count":27},{"year":2021,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2021-09-27T00:00:00"}
